These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21220769)

  • 1. Escherichia coli ST131 producing extended-spectrum β-lactamases plus VIM-1 carbapenemase: further narrowing of treatment options.
    Mantengoli E; Luzzaro F; Pecile P; Cecconi D; Cavallo A; Attala L; Bartoloni A; Rossolini GM
    Clin Infect Dis; 2011 Mar; 52(5):690-1. PubMed ID: 21220769
    [No Abstract]   [Full Text] [Related]  

  • 2. Escherichia coli producing KPC-2 carbapenemase: first report in Brazil.
    D'Alincourt Carvalho-Assef AP; Leão RS; da Silva RV; Ferreira AG; Seki LM; Asensi MD; Marques EA
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):337-8. PubMed ID: 20850249
    [No Abstract]   [Full Text] [Related]  

  • 3. Ciprofloxacin-resistant, CTX-M-15-producing Escherichia coli ST131 clone in extraintestinal infections in Italy.
    Cerquetti M; Giufrè M; García-Fernández A; Accogli M; Fortini D; Luzzi I; Carattoli A
    Clin Microbiol Infect; 2010 Oct; 16(10):1555-8. PubMed ID: 20121822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli.
    Oteo J; Bautista V; Lara N; Cuevas O; Arroyo M; Fernández S; Lázaro E; de Abajo FJ; Campos J;
    J Antimicrob Chemother; 2010 Nov; 65(11):2459-63. PubMed ID: 20851815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway.
    Naseer U; Haldorsen B; Simonsen GS; Sundsfjord A
    Clin Microbiol Infect; 2010 Feb; 16(2):171-8. PubMed ID: 19548922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
    Oteo J; Orden B; Bautista V; Cuevas O; Arroyo M; Martínez-Ruiz R; Pérez-Vázquez M; Alcaraz M; García-Cobos S; Campos J
    J Antimicrob Chemother; 2009 Oct; 64(4):712-7. PubMed ID: 19671590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term study of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
    Polwichai P; Trakulsomboon S; Dejsirilert S; Thongmali O; Sawanpanyalert P; Aswapokee N; Buppanharun W
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S53-8. PubMed ID: 21294502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escherichia coli ST131 producing CTX-M-15 in Australia.
    Sidjabat HE; Derrington P; Nimmo GR; Paterson DL
    J Antimicrob Chemother; 2010 Jun; 65(6):1301-3. PubMed ID: 20378669
    [No Abstract]   [Full Text] [Related]  

  • 9. Isolation of fluoroquinolone-resistant O25b:H4-ST131 Escherichia coli with CTX-M-14 extended-spectrum β-lactamase from UK river water.
    Dhanji H; Murphy NM; Akhigbe C; Doumith M; Hope R; Livermore DM; Woodford N
    J Antimicrob Chemother; 2011 Mar; 66(3):512-6. PubMed ID: 21172781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spread of Escherichia coli O25b:H4-B2-ST131 producing CTX-M-15 and SHV-12 with high virulence gene content in Barcelona (Spain).
    Coelho A; Mora A; Mamani R; López C; González-López JJ; Larrosa MN; Quintero-Zarate JN; Dahbi G; Herrera A; Blanco JE; Blanco M; Alonso MP; Prats G; Blanco J
    J Antimicrob Chemother; 2011 Mar; 66(3):517-26. PubMed ID: 21177675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum-beta-lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolate.
    Lagacé-Wiens PR; Nichol KA; Nicolle LE; DeCorby M; McCracken M; Mulvey MR; Zhanel GG
    J Antimicrob Chemother; 2006 Jun; 57(6):1262-3. PubMed ID: 16565157
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular characterization of plasmids encoding CTX-M-15 extended-spectrum beta-lactamase associated with the ST131 Escherichia coli clone in Belgium.
    Montesinos I; Rodriguez-Villalobos H; De Mendonça R; Bogaerts P; Deplano A; Glupczynski Y
    J Antimicrob Chemother; 2010 Aug; 65(8):1828-30. PubMed ID: 20534625
    [No Abstract]   [Full Text] [Related]  

  • 13. High presence of extended-spectrum beta-lactamases and resistance to quinolones in clinical isolates of Escherichia coli.
    Sorlózano A; Gutiérrez J; de Dios Luna J; Oteo J; Liébana J; Soto MJ; Piédrola G
    Microbiol Res; 2007; 162(4):347-54. PubMed ID: 16564161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominance of CTX-M-2 and CTX-M-56 among extended-spectrum beta-lactamases produced by Klebsiella pneumoniae and Escherichia coli isolated in hospitals in Paraguay.
    Khan MA; Lemmens N; Riera E; Blonk T; Goedhart J; Van Belkum A; Goessens W; Hays JP; Van Westreenen M
    J Antimicrob Chemother; 2009 Dec; 64(6):1330-2. PubMed ID: 19854861
    [No Abstract]   [Full Text] [Related]  

  • 15. Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals.
    Ewers C; Grobbel M; Stamm I; Kopp PA; Diehl I; Semmler T; Fruth A; Beutlich J; Guerra B; Wieler LH; Guenther S
    J Antimicrob Chemother; 2010 Apr; 65(4):651-60. PubMed ID: 20118165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal infection due to extended-spectrum beta-lactamase-producing Escherichia coli: implications for antibiotic choice for spontaneous bacterial peritonitis.
    Paterson DL; Singh N; Gayowski T; Marino IR
    Clin Infect Dis; 1999 Mar; 28(3):683-4. PubMed ID: 10194100
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.
    Blanco M; Alonso MP; Nicolas-Chanoine MH; Dahbi G; Mora A; Blanco JE; López C; Cortés P; Llagostera M; Leflon-Guibout V; Puentes B; Mamani R; Herrera A; Coira MA; García-Garrote F; Pita JM; Blanco J
    J Antimicrob Chemother; 2009 Jun; 63(6):1135-41. PubMed ID: 19351692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France.
    Leflon-Guibout V; Blanco J; Amaqdouf K; Mora A; Guize L; Nicolas-Chanoine MH
    J Clin Microbiol; 2008 Dec; 46(12):3900-5. PubMed ID: 18842941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First case of New Delhi metallo-beta-lactamase 1-producing Escherichia coli infection in Japan.
    Chihara S; Okuzumi K; Yamamoto Y; Oikawa S; Hishinuma A
    Clin Infect Dis; 2011 Jan; 52(1):153-4. PubMed ID: 21148536
    [No Abstract]   [Full Text] [Related]  

  • 20. AmpC beta-lactamases in Escherichia coli: emergence of CMY-2-producing virulent phylogroup D isolates belonging mainly to STs 57, 115, 354, 393, and 420, and phylogroup B2 isolates belonging to the international clone O25b-ST131.
    Oteo J; Cercenado E; Cuevas O; Bautista V; Delgado-Iribarren A; Orden B; Pérez-Vázquez M; García-Cobos S; Campos J
    Diagn Microbiol Infect Dis; 2010 Jul; 67(3):270-6. PubMed ID: 20462723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.